Organon (OGN) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Organon Reports Results for the Second Quarter Ended June 30, 2022
August 4, 2022 7:30 AM EDTSecond quarter 2022 revenues of $1,585 million Second quarter diluted earnings per share from continuing operations of $0.92 and non-GAAP adjusted diluted earnings per share from continuing operations of $1.25 Both reported and non-GAAP adjusted diluted earnings per share include a negative impact of $0.30 for acquired in-process research and development (IPR&D) and milestones Adjusted EBITDA of $512 million, inclusive of $97 million of acquired IPR&D and milestones Board of Directors declares quarterly dividend of $0.28 per share Full year 2022 financial guidance ranges updated: Revenues range narrowed to $6.1 billion to $6.3 billion, and reflects... More
